Terapia medicamentosa em disfunção temporomandibular: revisão de literatura

Abstract

INTRODUCTION: Temporomandibular disorder (TMD) has been one of the musculoskeletal pain conditions in orofacial pain. Symptoms such as myalgia, arthralgia and these during movements of the jaw when opening and closing prevail in 70% of the population, considering the number of people who seek care, giving importance to the symptoms, are low. OBJECTIVES: This work aims to explore the pharmacology of medications used to treat temporomandibular disorders (TMDs), providing an overview of the different drugs available. The study of pharmacological options in TMD (temporomandibular dysfunction) is of great importance for health professionals, such as dentists, doctors and physiotherapists who work in the evaluation and treatment of this clinical condition. METHODOLOGY: 18 articles were selected that are present on platforms such as: sCielo, PubMed and Google Scholar, in the period published between 2013 and 2023, clinical trials, reviews, using Decs, Descriptors in Health Sciences: Facial Pain, Temporomandibular Joint, Temporomandibular Joint Dysfunction Syndrome, Systematic Review. RESULTS FINAL CONSIDERATIONS: This study aims to add knowledge from a theoretical point of view and assist professionals in choosing the best drug for a given case, considering the type, duration and intensity for each case. Subsequently enabling definitive and effective treatment, providing well-being to the patient.